1. Home
  2. HIT vs CASI Comparison

HIT vs CASI Comparison

Compare HIT & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIT
  • CASI
  • Stock Information
  • Founded
  • HIT 1964
  • CASI 1991
  • Country
  • HIT United States
  • CASI China
  • Employees
  • HIT N/A
  • CASI N/A
  • Industry
  • HIT Specialty Insurers
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIT Finance
  • CASI Health Care
  • Exchange
  • HIT Nasdaq
  • CASI Nasdaq
  • Market Cap
  • HIT 38.2M
  • CASI 33.4M
  • IPO Year
  • HIT 2024
  • CASI 1996
  • Fundamental
  • Price
  • HIT $0.65
  • CASI $1.98
  • Analyst Decision
  • HIT
  • CASI Strong Buy
  • Analyst Count
  • HIT 0
  • CASI 1
  • Target Price
  • HIT N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • HIT 857.6K
  • CASI 15.4K
  • Earning Date
  • HIT 04-14-2025
  • CASI 05-13-2025
  • Dividend Yield
  • HIT N/A
  • CASI N/A
  • EPS Growth
  • HIT N/A
  • CASI N/A
  • EPS
  • HIT 0.02
  • CASI N/A
  • Revenue
  • HIT $22,380,959.00
  • CASI $28,537,000.00
  • Revenue This Year
  • HIT $119,032.48
  • CASI $66.12
  • Revenue Next Year
  • HIT N/A
  • CASI $51.37
  • P/E Ratio
  • HIT $37.15
  • CASI N/A
  • Revenue Growth
  • HIT 11.24
  • CASI N/A
  • 52 Week Low
  • HIT $0.51
  • CASI $1.88
  • 52 Week High
  • HIT $7.59
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • HIT N/A
  • CASI 45.04
  • Support Level
  • HIT N/A
  • CASI $1.91
  • Resistance Level
  • HIT N/A
  • CASI $2.14
  • Average True Range (ATR)
  • HIT 0.00
  • CASI 0.20
  • MACD
  • HIT 0.00
  • CASI 0.00
  • Stochastic Oscillator
  • HIT 0.00
  • CASI 24.49

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: